|
|
Volumn 31, Issue 1-2, 1999, Pages 1155-1156
|
|
Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
DILTIAZEM;
METHYLPREDNISOLONE;
OKT 3;
PREDNISOLONE;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY ALLOGRAFT;
KIDNEY BIOPSY;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SURVIVAL;
TREATMENT OUTCOME;
ANTILYMPHOCYTE SERUM;
AZATHIOPRINE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
METHYLPREDNISOLONE;
MUROMONAB-CD3;
SURVIVAL RATE;
TIME FACTORS;
|
|
EID: 0032985348
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01943-5 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (4)
|
